Though more research is needed to understand who might benefit from GLP-1 agonists for addiction, early studies suggest that the approach holds promise.

A randomized, placebo-controlled trial validates a side effect frequently observed by doctors and patients. A new study from ...

Conagra and General Mills are among the food companies offering special options for people on GLP-1 drugs, but the products ...

New research suggests semaglutide, marketed as Ozempic for diabetes and Wegovy for obesity, could help people reduce their alcohol consumption.

Taking tiny doses of GLP-1 medication has been touted for weight management, perimenopause symptoms, even longevity. But is ...